Skip to main content
Equibles
RANI logo

RANI · Rani Therapeutics Holdings, Inc. · Earnings Call Transcripts & Audio

Track RANI — free

Use RANI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RANI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.84 +0.02 (+2.51%) At close · Sep 11
Rebalance outlook locked
Market Cap
$117.45M
Shares
139.40M

Rani Therapeutics Holdings, Inc. Earnings Call Transcripts

Quarterly earnings calls for Rani Therapeutics Holdings, Inc. (RANI), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $ $5.89M '21 Q4 22-03-29 · $1.03M −$8.95M '24 Q4 25-03-31 LATEST ▲42.1% $1.46M −$10.30M '25 Q4 26-03-26
Conference
Investor event
2026-08-12
Rani Therapeutics Holdings, Inc. (RANI) August 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-03-26
Rani Therapeutics Holdings, Inc. (RANI) Q4 2025 Earnings Call Transcript
Confident tone RaniPill platform validation RT114 (oral bispecific GLP-1/GLP-2) clinical progress Chugai partnership
Revenue
$1.46M*
▲ 42.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q4
2025-03-31
Rani Therapeutics Holdings, Inc. (RANI) Q4 2024 Earnings Call
Revenue
$1.03M*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q4
2024-03-20
Rani Therapeutics Holdings, Inc. (RANI) Q4 2023 Earnings Call Transcript
Confident tone RT-111 Phase 1 ustekinumab biosimilar results Celltrion partnership and biosimilar supply Obesity market opportunity and pipeline
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q4
2023-03-22
Rani Therapeutics Holdings, Inc. (RANI) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q4
2022-03-29
Rani Therapeutics Holdings, Inc. (RANI) Q4 2021 Earnings Call Transcript
Revenue
$*
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–6 of 6 earnings calls
Key facts CIK 1856725 CUSIP 753018100 13F (30d) 22 filings 22 filers Visit website Investor relations